← Back to Search

Surveillance Strategies for Lung Cancer(WTS Trial)

Waitlist Available
Led By Michael K Gould, MD, MS
Research Sponsored by Kaiser Permanente
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
at least one nodule measuring ≤15 mm in average diameter on chest CT.
Be older than 18 years old
Must not have
Be younger than 18 years old
Screening 3 weeks
Treatment Varies
Follow Upup to 4 years
Awards & highlights
No Placebo-Only Group

WTS Trial Summary

This trial will compare two different protocols for follow-up imaging of small pulmonary nodules discovered on chest CT scans.

Eligible Conditions
  • Solitary Pulmonary Nodule
  • Pulmonary Lesion
  • Lung Cancer
  • Non-Small Cell Lung Cancer

WTS Trial Eligibility Criteria

Inclusion Criteria

You will be eligible if you check “Yes” for the criteria below

WTS Trial Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~up to 4 years
This trial's timeline: 3 weeks for screening, Varies for treatment, and up to 4 years for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
Malignant Neoplasms
Secondary outcome measures
Anxiety, measured with the State Anxiety Inventory, 6-item
Fetal Distress
Exposure to ionizing radiation, using the computed tomography dose index (CTDIvol), measured in mGy (milliGray)
+6 more

Awards & Highlights

No Placebo-Only Group
All patients enrolled in this study will receive some form of active treatment.

WTS Trial Design

2Treatment groups
Active Control
Group I: More Frequent CT SurveillanceActive Control1 Intervention
Chest CT scans to be repeated at 3, 6, 12 and/or 24 months, depending on patient risk factors and nodule size and attenuation (density)
Group II: Less Frequent CT SurveillanceActive Control1 Intervention
Chest CT scans to be repeated at 3, 6, 12 and/or 24 months, depending on patient risk factors and nodule size and attenuation (density). Overall, participants in the less frequent arm are expected to undergo 30% fewer surveillance imaging tests.

Find a Location

Who is running the clinical trial?

Kaiser PermanenteLead Sponsor
528 Previous Clinical Trials
23,759,390 Total Patients Enrolled
Patient-Centered Outcomes Research InstituteOTHER
534 Previous Clinical Trials
29,919,419 Total Patients Enrolled
University of California, DavisOTHER
895 Previous Clinical Trials
4,993,243 Total Patients Enrolled

Media Library

More Frequent CT Surveillance Clinical Trial Eligibility Overview. Trial Name: NCT02623712 — N/A
Solitary Pulmonary Nodule Research Study Groups: More Frequent CT Surveillance, Less Frequent CT Surveillance
Solitary Pulmonary Nodule Clinical Trial 2023: More Frequent CT Surveillance Highlights & Side Effects. Trial Name: NCT02623712 — N/A
More Frequent CT Surveillance 2023 Treatment Timeline for Medical Study. Trial Name: NCT02623712 — N/A

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

What are the main goals of this clinical experiment?

"This two-year long clinical trial aims to evaluate the prevalence of T1a stage or greater cancerous nodules according to AJCC staging system (7th edition). Secondary objectives involve assessing survival time from date of diagnosis, days between identification and diagnosis, and radiation exposure as measured by mGy (milliGray) CTDIvol."

Answered by AI

Are there any recruitment opportunities available for this trial?

"According to clinicaltrials.gov, this study is no longer recruiting participants after having first been posted on March 6th 2017 and its most recent update occurring on September 30th 2022. Nevertheless, 1932 other medical studies are presently seeking potential candidates for their trials."

Answered by AI

Who else is applying?

What state do they live in?
What site did they apply to?
Kaiser Permanente Southern California
What portion of applicants met pre-screening criteria?
Met criteria
How many prior treatments have patients received?
Recent research and studies
~4591 spots leftby Nov 2024